Olaparib-Induced Severe Folate Deficiency in a Patient With Advanced Ovarian Cancer

J Oncol Pract. 2019 Jul;15(7):405-407. doi: 10.1200/JOP.18.00705. Epub 2019 Jun 14.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Female
  • Folic Acid / therapeutic use
  • Folic Acid Deficiency / chemically induced*
  • Folic Acid Deficiency / drug therapy
  • Humans
  • Middle Aged
  • Ovarian Neoplasms / drug therapy
  • Phthalazines / adverse effects*
  • Piperazines / adverse effects*

Substances

  • Antineoplastic Agents
  • Phthalazines
  • Piperazines
  • Folic Acid
  • olaparib